DK651087A - Renininhibitorer iii, deres fremstilling og anvendelse - Google Patents

Renininhibitorer iii, deres fremstilling og anvendelse

Info

Publication number
DK651087A
DK651087A DK651087A DK651087A DK651087A DK 651087 A DK651087 A DK 651087A DK 651087 A DK651087 A DK 651087A DK 651087 A DK651087 A DK 651087A DK 651087 A DK651087 A DK 651087A
Authority
DK
Denmark
Prior art keywords
preparation
application
inhibitors iii
pure inhibitors
pure
Prior art date
Application number
DK651087A
Other languages
English (en)
Other versions
DK651087D0 (da
Inventor
James Perry Hudspeth
James Stanley Kaltenbronn
Joseph Thomas Repine
William Howard Roark
Michael Andrew Stier
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/941,966 external-priority patent/US4735933A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK651087D0 publication Critical patent/DK651087D0/da
Publication of DK651087A publication Critical patent/DK651087A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK651087A 1986-12-15 1987-12-11 Renininhibitorer iii, deres fremstilling og anvendelse DK651087A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/941,966 US4735933A (en) 1986-12-15 1986-12-15 Renin inhibitors III
US07/113,277 US4895834A (en) 1986-12-15 1987-11-02 Renin inhibitors III

Publications (2)

Publication Number Publication Date
DK651087D0 DK651087D0 (da) 1987-12-11
DK651087A true DK651087A (da) 1988-06-16

Family

ID=26810874

Family Applications (1)

Application Number Title Priority Date Filing Date
DK651087A DK651087A (da) 1986-12-15 1987-12-11 Renininhibitorer iii, deres fremstilling og anvendelse

Country Status (10)

Country Link
US (1) US4895834A (da)
EP (1) EP0271862A3 (da)
KR (1) KR880007562A (da)
AU (1) AU605212B2 (da)
DK (1) DK651087A (da)
FI (1) FI875455A (da)
NO (1) NO875199L (da)
NZ (1) NZ222754A (da)
PH (2) PH23734A (da)
PT (1) PT86374B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921855A (en) * 1987-06-22 1990-05-01 Fujisawa Pharmaceutical Co., Ltd. New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same
EP0326364B1 (en) * 1988-01-26 1994-06-22 Sankyo Company Limited Renin inhibitory oligopeptides, their preparation and use
DE3915755A1 (de) * 1989-05-13 1990-11-29 Bayer Ag Fungizide mittel sowie substituierte aminosaeureamid-derivate und deren herstellung
US5821232A (en) * 1990-05-11 1998-10-13 Pfizer Inc. Synergistic therapeutic compositions and methods
BR9106438A (pt) 1990-05-11 1993-05-18 Pfizer Composicoes terapeuticas sinergisticas e processos
US5244910A (en) * 1990-08-15 1993-09-14 Abbott Laboratories Renin inhibitors
US5258362A (en) * 1991-06-11 1993-11-02 Abbott Laboratories Renin inhibiting compounds
US5212185A (en) * 1992-08-14 1993-05-18 G. D. Searle & Co. Piperidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
US5780494A (en) * 1994-11-14 1998-07-14 G. D. Searle & Co. Piperidinyl-terminated alkylamino ethynl alanine amino diol compounds for treatment of hypertension
EP1723962A1 (en) 2005-05-19 2006-11-22 IMBA-Institut für Molekulare Biotechnologie GmbH Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0114993B1 (en) * 1982-12-27 1990-05-16 Merck & Co. Inc. Renin inhibitory tripeptides
EP0173481A3 (en) * 1984-08-06 1988-12-21 The Upjohn Company Peptides
SU1676454A3 (ru) * 1984-11-30 1991-09-07 Санкио Компани Лимитед (Фирма) Способ получени пептидов или их фармацевтически приемлемых солей
KR870005013A (ko) * 1985-11-29 1987-06-04 가와무라 요시부미 레닌-억제 올리고펩티드, 그의 제조방법 및 용도
US4735933A (en) * 1986-12-15 1988-04-05 Warner-Lambert Company Renin inhibitors III
NZ222755A (en) * 1986-12-23 1989-11-28 Warner Lambert Co Renin inhibiting acyl peptide derivatives containing two to four amino acid residues, and pharmaceutical compositions
FI89058C (fi) * 1987-02-27 1993-08-10 Yamanouchi Pharma Co Ltd Foerfarande foer framstaellning av som remin-inhibitorer anvaenda 2-(l-alanyl-l-histidylamino)-butanol-derivat
DK523288A (da) * 1987-10-06 1989-04-07 Hoffmann La Roche Aminosyrederivater

Also Published As

Publication number Publication date
PT86374B (pt) 1990-11-20
NO875199D0 (no) 1987-12-14
EP0271862A3 (en) 1990-11-14
PH24655A (en) 1990-09-07
AU605212B2 (en) 1991-01-10
FI875455A0 (fi) 1987-12-11
NO875199L (no) 1988-06-16
NZ222754A (en) 1989-12-21
PH23734A (en) 1989-11-03
US4895834A (en) 1990-01-23
DK651087D0 (da) 1987-12-11
PT86374A (en) 1988-01-01
KR880007562A (ko) 1988-08-27
FI875455A (fi) 1988-06-16
AU8207287A (en) 1988-06-30
EP0271862A2 (en) 1988-06-22

Similar Documents

Publication Publication Date Title
DK546186A (da) Substituerede benzylethere, deres fremstilling og anvendelse
DK129386A (da) Iodpropargylethere, deres fremstilling og anvendelse
DK354687D0 (da) 7-acyloxy-6-aminoacyloxypolyoxylabdaner, deres fremstilling og anvendelse
DK519586A (da) 1-aryl-4-nitro-pyrazoler, deres fremstilling og anvendelse
DK633287A (da) Carbamoylimidazo-derivater, deres fremstilling og anvendelse
DK651087D0 (da) Renininhibitorer iii, deres fremstilling og anvendelse
DK28685A (da) Azolyl-aryl-alkanol-derivater, deres fremstilling og anvendelse
DK235787A (da) Tripeptidderivater, deres fremstilling og anvendelse
DK380286A (da) Sulfonamider, deres fremstilling og anvendelse
DK360189D0 (da) S-adenosyl-methionin-decarboxylase-inhibitorer, deres fremstilling og anvendelse
DK213387D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK617886D0 (da) 1-aryl-pyrazoler, deres fremstilling og anvendelse
DK212687A (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK396886A (da) Gem-dihalogen-1,8-diamino-4-azaoctaner, deres fremstilling og anvendelse
DK675687D0 (da) Substituerede n-methylisoxazolidiner, deres fremstilling og anvendelse
DK625287A (da) 1-aryloxy-3-amino-2-propanoler, deres fremstilling og anvendelse
DK377786A (da) 1-aryl-5-hydrazino-pyrazoler, deres fremstilling og anvendelse
DK136985A (da) Sulfamoylguanidin-derivater, deres fremstilling og anvendelse
DK126987A (da) Pyrimidoindoler, deres fremstilling og anvendelse
DK393986A (da) Lactamamider, deres fremstilling og anvendelse
DK136885A (da) Thiatriazin-derivater, deres fremstilling og anvendelse
DK451486D0 (da) Alkenylazoler, deres fremstilling og anvendelse
DK127087D0 (da) Phenylsulfonyl-pyridanaldoximer, deres fremstilling og anvendelse
DK540786D0 (da) 2-hydroxybenzamider, deres fremstilling og anvendelse
DK444087D0 (da) Piperidinforbindelser, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment